arrow
M

Michele Bartoletti

Humanitas University
H指数:50
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of Aztreonam-avibactam for infections caused by MBL-producing Enterobacterales

使用他唑巴坦-阿维巴坦治疗产金属β-内酰胺酶肠杆菌科细菌引起的感染

2026-04-020
OAAI
The Impact of body mass index on Survival and Surgical Outcomes in Ovarian Cancer: Insights from the MITO Trials

体重指数对卵巢癌患者生存及手术结果的影响:来自MITO试验的见解

2025-11-010
PRE
RECURRENCE PATTERNS AND PROGNOSTIC FACTORS IN VULVAR EXTRAMAMMARY PAGET’S DISEASE: A 10-YEAR SINGLE INSTITUTION EXPERIENCE

外阴外乳腺佩吉特病复发模式和预后因素:一项10年单机构经验

2025-10-100
PRE
Why do echinocandins fail? Identifying Key Predictors to Improve Clinical Outcomes of Candida Bloodstream Infections: a Retrospective Multicentre Cohort Study

为什么棘白菌素治疗失败?识别关键预测因子以改善念珠菌血流感染的临床结局:一项回顾性多中心队列研究

2025-09-030
OAAI
The Role of Rapid and Advanced Microbiological Methods in Critical Care: 2025 EMANUELE RUSSO Delphi Consensus

快速和高级微生物学方法在重症监护中的作用:2025 EMANUELE RUSSO 德尔菲共识

2025-08-280
OAAI
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections

铜绿假单胞菌血流感染中30天死亡的风险因素及经验性治疗的作用

2025-07-280
PRE
Management of COVID-19 in Immunocompromised Patients: An ESCMID Consensus Document

免疫抑制患者中COVID-19的管理:ESCMID共识文件

2025-06-230
PRE
Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective study

铜绿假单胞菌血流感染在内科病房中的研究:一项大型意大利多中心回顾性研究

2025-05-190
OA
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's response

比较不同临床场景下抗生素处方的大型语言模型:作者回复

2025-05-070
PRE
Cefiderocol for Gram-negative infections: comparing monotherapy and combination therapy in the multicenter CEFI-BAC study

西地尼布用于革兰氏阴性菌感染:比较多中心CEFI-BAC研究中单药疗法与联合疗法

2025-04-240
OA
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?

比较不同临床场景下抗生素处方的大型语言模型:哪个表现更好?

2025-03-190
OAAI
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy
2025-03-010
OAAI
Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of Pseudomonas aeruginosa bacteraemia: new kids on the ICU block?

抗假单胞菌头孢菌素与哌拉西林/他唑巴坦或碳青霉烯类抗生素对铜绿假单胞菌菌血症的确定性抗生素治疗: ICU阻滞的新孩子?

2025-03-010
PRE
Homologous Recombination Repair Status In Advanced Endometrial Cancer. An Exploratory Biomarker Analysis From The Randomized, Phase II MITO END 3 Trial

高级子宫内膜癌的同源重组修复状态。来自随机、II期MITO END 3试验的探索性生物标志物分析

2025-02-010
PRE
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance
2024-12-180
OAAI
Evolution of the Evidence for the Management of COVID-19 in Hematologic Malignancies: A Systematic Literature Review of Remdesivir

血液系统恶性肿瘤患者COVID-19管理证据的演变:一项关于瑞德西韦的系统文献综述

BLOOD
IF23.1
2024-11-050
PRE